Amendment: SEC Form S-4/A filed by Rallybio Corporation
S-4/A - Rallybio Corp (0001739410) (Filer)
- NVIDIA Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - NVIDIA CORP (0001045810) (Filer)
- SEC Form 144 filed by Monopar Therapeutics Inc.
144 - Monopar Therapeutics (0001645469) (Subject)
- SEC Form 144 filed by Live Oak Bancshares Inc.
144 - Live Oak Bancshares, Inc. (0001462120) (Subject)
- SEC Form 6-K filed by MaxsMaking Inc.
6-K - MaxsMaking Inc. (0002008007) (Filer)
- SEC Form N-CSRS filed by Royce Micro-Cap Trust Inc.
N-CSRS - ROYCE MICRO-CAP TRUST, INC. (0000912147) (Filer)
- 21shares Sui ETF filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - 21Shares Sui Staking ETF (0002061626) (Filer)
- NVIDIA Announces Financial Results for Second Quarter Fiscal 2027
Revenue of $96.2 billion, up 106% from a year agoData Center revenue of $89.0 billion, up 117% from a year ago SANTA CLARA, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ:NVDA) today reported revenue for the second quarter ended July 26, 2026, of $96.2 billion, up 18% from the previous quarter and up 106% from a year ago. For the quarter, GAAP and non-GAAP gross margins were both 75.0%. GAAP and non-GAAP earnings per diluted share were $2.46 and $2.22, respectively. "AI has reached its inflection point. It’s doing useful work. Its tokens are productive and profitable. Now, compute is revenue," said Jensen Huang, founder and CEO of NVIDIA. "And demand is accelerating. This time
- Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
Phibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its fourth quarter and fiscal year ended June 30, 2026 and provided its financial guidance for the fiscal year ending June 30, 2027. Highlights for the three months ended June 30, 2026 (compared to the three months ended June 30, 2025) – Net sales of $396.7 million, an increase of $18.1 million, or 5% – Net income of $21.7 million, an increase of $4.5 million, or 26% – Diluted earnings per share of $0.53, an increase of $0.11, or 26% – Adjusted EBITDA of $64.2 million, an increase of $14.3 million, or 29% – Adjusted net income of $35.0 million, an increase of $9.4 mil
- SEC Form 144 filed by LendingClub Corporation
144 - Happen, Inc. (0001409970) (Subject)
- SEC Form 424B3 filed by Rocket Lab Corporation
424B3 - Rocket Lab Corp (0001819994) (Filer)
- SEC Form N-CSRS filed by Royce Global Trust Inc.
N-CSRS - ROYCE GLOBAL TRUST, INC. (0001514490) (Filer)
- SEC Form 10-Q filed by Bath & Body Works Inc.
10-Q - Bath & Body Works, Inc. (0000701985) (Filer)
- SEC Form 144 filed by Monopar Therapeutics Inc.
144 - Monopar Therapeutics (0001645469) (Subject)
- SEC Form 10-Q filed by The J.M. Smucker Company
10-Q - J M SMUCKER Co (0000091419) (Filer)
- HP Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - HP INC (0000047217) (Filer)
- SEC Form 6-K filed by Grupo Cibest S.A.
6-K - Grupo Cibest S.A. (0002058897) (Filer)
- SEC Form 144 filed by Omeros Corporation
144 - OMEROS CORP (0001285819) (Subject)
- Amendment: SEC Form S-1/A filed by Starfighters Space Inc.
S-1/A - Starfighters Space, Inc. (0001947016) (Filer)